Top Wall Street Stories: EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), SunPower Corporation (NASDAQ:SPWR), HP Inc. (NYSE:HPQ), Insmed Incorporated (NASDAQ:INSM),

Wedbush restated their outperform rating on shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) in a research report sent to investors on Tuesday, MarketBeat.Com reports. Wedbush currently has a $16.00 target price on the biopharmaceutical company’s stock.

EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) belongs to Healthcare sector. Its weekly performance is -4.25%. On last trading day company shares ended up at $2.93. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) distance from 50-day simple moving average (SMA50) is -7.38%.

SunPower Corporation (NASDAQ:SPWR) announced the signing of a new Power Purchase Agreement (PPA) with the Escondido Union High School District in California, which will see SunPower build 2 MW worth of solar power systems at four schools in the district.

SunPower Corporation (NASDAQ:SPWR) shares advanced 10.51% in last trading session and ended the day at $22.71. SPWR Gross Margin is 15.50% and its return on assets is -4.20%. SunPower Corporation (NASDAQ:SPWR) quarterly performance is -2.11%.

HP Inc. (NYSE:HPQ) board of directors has declared a cash dividend of $0.124 per share on the company’s common stock. The dividend, the second in HP Inc.’s fiscal year 2016, is payable on April 6, 2016, to stockholders of record as of the close of business on March 9, 2016.

On 24 February, HP Inc. (NYSE:HPQ) shares advanced 4.95% and was closed at $10.82. HPQ EPS growth in last 5 year was -7.60%. HP Inc. (NYSE:HPQ) year to date (YTD) performance is -8.61%.

Insmed Incorporated (NASDAQ:INSM) said that, it will be releasing its earnings data before the market opens on Thursday, February 25th.

Insmed Incorporated (NASDAQ:INSM) ended the last trading day at $12.39. Company weekly volatility is calculated as 5.97% and price to cash ratio as 2.46. Insmed Incorporated (NASDAQ:INSM) showed a weekly performance of -8.09%.

On 22 February, Intelsat S.A. (NYSE:I) announced preliminary financial results for the three months and full year ended December 31, 2015. Intelsat reported preliminary total revenue of $571.3 million for the three months ended December 31, 2015.

Intelsat S.A. (NYSE:I) shares fell -12.15% in last trading session and ended the day at $2.17. I Gross Margin is 86.00% and its return on assets is 1.20%. Intelsat S.A. (NYSE:I) quarterly performance is -64.54%.

Leave a Reply

Your email address will not be published. Required fields are marked *